The Role of Inteleukin-5 (IL-5 ) in Vivo: Studies with IL-5 Deficient Mice

Memorias do Instituto Oswaldo Cruz

Volumn 92 SUPPL. 2, Issue , 1997, Pages 63-68

  Matthaei, Klaus I ^a   Foster, Paul S ^a   Young, Ian G ^a  

^a Biology and Environment   (Australia)

Author keywords

B 1 B lymphocytes; Eosinophils; IgA production; Interleukin 5; Knockout; Parasite infection

Indexed keywords

VERMES;

IMMUNOGLOBULIN A; INTERLEUKIN 5;

ANIMAL; B LYMPHOCYTE; DISEASE MODEL; EOSINOPHIL; IMMUNOLOGY; MOUSE; MOUSE MUTANT; PARASITOSIS; PHYSIOLOGY; REVIEW;

ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EOSINOPHILS; IMMUNOGLOBULIN A; INTERLEUKIN-5; MICE; MICE, KNOCKOUT; PARASITIC DISEASES;

EID: 0031311343     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761997000800010     Document Type: Article

References (38)

1. Bao S, Beagley KW, Matthaei KI, Caristo V, Young IG, Husband AJ in preparation. B-1 B cell development is IL-5 dependent.
2. Beagley KW, Eldridge JH, Kiyono H, Everson MP, Koopman WJ, Honjo T, McGhee JR 1988. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol 141: 2035-2042.
3. Bertolini JN, Sanderson CJ, Benson EM 1993. Human interleukin-5 induces staphylococcal A Cowan 1 strain-activated human B cells to secrete IgM. Eur J Immunol 23: 398-402.
4. Butterworth AE 1984. Cell-mediated damage to helminths. Adv Parasitol 23: 143-235.
5. Campbell HD, Sanderson CJ, Wang Y, Hort Y, Martinson ME, Tucker WQ, Stellwagen A, Strath M, Young IG 1988. Isolation, structure and expression of cDNA and genomic clones for murine eosinophil differentiation factor. Comparison with other eosinophilopoietic lymphokines and identity with interleukin-5. Eur J Biochem 174: 345-352.
6. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245: 308-310.
7. Coffman RL, Shrader B, Carty J, Mosmann TR, Bond MW 1987. A mouse T cell product that preferentially enhances IgA production. I. Biologic characterization. J Immunol 139: 3685-3690.
8. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195-201.
9. Hardy RR, Hayakawa K 1994. CDS B cells, a fetal B cell lineage. Adv Immunol 55: 297-339.
10. Herndon FJ, Kayes SG 1992. Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. J Immunol 149: 3642-3647.
11. Kearney JF, Bartels J, Hamilton AM, Lehuen A, Solvason N, Vakil M 1992. Development and function of the early B cell repertoire. Int Rev Immunol 8: 247-257.
12. Kinashi T, Harada N, Severinson E, Tanabe T, Sideras P, Konishi M, Azuma C, Tominaga A, Bergstedt LS, Takahashi M 1986. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324: 70-73.
13. Kocks C, Rajewsky K 1989. Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways. Annu Rev Immunol 7: 537-559.
14. Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG, Matthaei KI 1996. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4: 15-24.
15. Kunimoto DY, Nordan RP, Strober W 1989. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J Immunol 143: 2230-2235.
16. Matthaei KI, Mould AW, Foster PS, Young IG in preparation. Eosinophilia in the absence of IL-5.
17. Milbourne EA, Howell MJ 1993. Eosinophil differentiation in response to Fasciola hepatica and its excretory/secretory antigens. Int J Parasitol 23: 1005-1009.
18. Morris CF, Simeonovic CJ, Fung MC, Wilson JD, Hapel AJ 1995. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. J Immunol 154: 2470-2482.
19. Mould AW, Matthaei KI, Young IG, Foster PS 1997. Relationship between Interleukin-5 and Eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 99: 1064-1071.
20. Murray PD, McKenzie DT, Swain SL, Kagnoff MF 1987. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol 139: 2669-2674.
21. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG 1994. The role of cytokines in gestation. Crit Rev Immunol 14: 239-292.
22. Ovington KS, McKie K, Matthaei KI, Young IG, Behm CA in preparation. Regulation of Strongyloides ratti infections in mice: a role for interleukin-5.
23. Ovington KS, Morgan D, Matthaei KI, Young IG, Behm CA unpublished.
24. Sanderson CJ 1992. Interleukin-5, eosinophils, and disease. Blood 79: 3101-3109.
25. Simeonovic CJ, Ceredig R, Wilson JD 1990. Effect of GK1.5 monoclonal antibody dosage on survival of pig proislet xenografts in CD4+ T cell-depleted mice. Transplantation 49: 849-856.
26. Simeonovic CJ, Townsend MJ, Wilson JD, McKenzie KUS, Ramsay AJ, Matthaei KI, Mann DA, Young IG 1997. Eosinophils are not required for the rejection of neovascularized fetal pig proislet xenografts in mice. J Immunol 158: 2490-2499.
27. Sonoda E, Hitoshi Y, Yamaguchi N, Ishii T, Tominaga A, Araki S, Takatsu K 1992. Differential regulation of IgA production by TGF-beta and IL-5: TGF-beta induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgA-secreting cells. Cell Immunol 140: 158-172.
28. Stevceva L, Pavli P, Doe W, Husband A, Young IG, Matthaei KI in preparation. The role of Interleukin-5 in colonic inflammation.
29. Takahashi T, Yamaguchi N, Mita S, Yamaguchi Y, Suda T, Tominaga A, Kikuchi Y, Miura Y, Takatsu K 1990. Structural comparison of murine T-cell (B151K12)-derived T-cell-replacing factor (IL-5) with rIL-5: dimer formation is essential for the expression of biological activity. Mol Immunol 27: 911-920.
30. Takamoto M, Kusama Y, Takatsu K, Nariuchi H, Sugane K 1995. Occurrence of interleukin-5 production by CD4- CD8- (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canis. Immunology 85: 285-291.
31. Takamoto M, Ovington KS, Behm CA, Sugane K, Young IG, Matthaei KI 1997. Eosinophilia, parasite burden and lung damage in Toxocara canis infections in C57BL/6 mice genetically deficient in IL-5. Immunolog 90: 511-517.
32. Takatsu K, Harada N, Hara Y, Takahama Y, Yamada G, Dobashi K, Hamaoka T 1985. Purification and physicochemical characterization of murine T cell replacing factor (TRF). J Immunol 134: 382-389.
33. Tominaga A, Takaki S, Koyama N, Katoh S, Matsumoto R, Migita M, Hitoshi Y, Hosoya Y, Yamauchi S, Kanai Y 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med 173: 429-437.
34. Vallence BA, Blennerhassett PA, Matthaei KI, Young IG, Collins SM in preparation, Interleukin-5 deficient mice have increased worm burdens and lack intestinal eosinophilia following both primary and secondary T. spiralis infections.
35. Walsh RE, Gaginella TS 1991. The eosinophil in inflammatory bowel disease. Scand J Gastroenterol 26: 1217-1224.
36. Wetzel GD 1989. Interleukin 5 regulation of peritoneal Ly-1 B lymphocyte proliferation, differentiation and autoantibody secretion. Eur J Immunol 19: 1701-1707.
37. Whittle BL, Smith RM, Matthaei KI, Young IG, Verma NK in press. Interleukin-5 Expressed by an Attenuated Strain of Salmonella serotype Dublin Enhances Specific Mucosal IgA Response in vivo. J Med Microbiol.
38. Yoshida T, Ikuta K, Sugaya H, Maki K, Takagi M, Kanazawa H, Sunaga S, Kinashi T, Yoshimura K, Miyazaki J, Takaki S, Takatsu K 1996. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-defi-cient mice. Immunity 4: 483-494.